Skip to main content
K. Magnus Karlberg

K. Magnus Karlberg

Partner
T +1 212 506 2681
  • RSS Icon
Experience
  • AddRemove
  • Build a Report 

Select Representative Matters

Banking & Insurance

  • Canadian Imperial Bank of Commerce in its acquisition of PrivateBancorp, Inc. (NASDAQ: PVTB) for cash and stock consideration valued at approximately US$5 billion.
  • Canadian Imperial Bank of Commerce in its $1 billion sale of a minority stake in American Century Investments Inc.
  • JPMorgan Chase & Co. in connection with its divestiture of the assets of its subsidiary, Plymouth Park Tax Services, LLC.
  • Everest Reinsurance Holdings, Inc. in the sale of Mt. McKinley Insurance Company to Clearwater Insurance Company, an affiliate of Fairfax Financial Holdings Limited.
  • Assured Guaranty Ltd. in its $810 million acquisition of Radian Asset Assurance Inc., a US-based provider of financial guaranty insurance and reinsurance, from Radian Group Inc.
  • Assured Guaranty Ltd. in its $450 million acquisition of CIFG Holding Inc.
  • Bristol-Myers Squibb in a $1.4 billion pension de-risking transaction with The Prudential.
  • OneBeacon Insurance Group Ltd. in connection with its divestiture of its runoff business to an affiliate of Armour Group Holdings Ltd.

Life Science & Pharmaceuticals

  • Nestlé S.A. in its $11.85 billion acquisition of Pfizer’s infant nutrition business.
  • Nestlé S.A. in its on-sale of Australian, South African and Latin American infant nutrition businesses to the Aspen Group.
  • Nestlé S.A. in the restructuring of its joint venture (Dairy Partners Americas) with Fonterra Cooperative Group of New Zealand for the manufacture of milk powders and the manufacture, distribution and sale of flavored milks and other dairy products throughout North, Central and South America and the Caribbean.
  • Nestlé Health Science in its license and collaboration transaction with Seres Therapeutics, Inc. for the development of biologics based on the human microbiome in certain indications.  The transaction provides for an upfront payment to Seres of $120 million and contingent payments tied to development and sales milestones.
  • Sellers in the sale of County Line Pharmaceuticals LLC to Alvogen Group, Inc.
  • Slayback Pharma in connection with its $60 million committed financing from KKR.
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.